Cargando…
Correction: New insights into epigenetic regulation of resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms and therapeutic opportunities
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764574/ https://www.ncbi.nlm.nih.gov/pubmed/36536374 http://dx.doi.org/10.1186/s40164-022-00359-x |
| _version_ | 1784853301556150272 |
|---|---|
| author | Dai, Mengyuan Liu, Miao Yang, Hua Küçük, Can You, Hua |
| author_facet | Dai, Mengyuan Liu, Miao Yang, Hua Küçük, Can You, Hua |
| author_sort | Dai, Mengyuan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9764574 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97645742022-12-21 Correction: New insights into epigenetic regulation of resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms and therapeutic opportunities Dai, Mengyuan Liu, Miao Yang, Hua Küçük, Can You, Hua Exp Hematol Oncol Publisher Correction BioMed Central 2022-12-19 /pmc/articles/PMC9764574/ /pubmed/36536374 http://dx.doi.org/10.1186/s40164-022-00359-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Publisher Correction Dai, Mengyuan Liu, Miao Yang, Hua Küçük, Can You, Hua Correction: New insights into epigenetic regulation of resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms and therapeutic opportunities |
| title | Correction: New insights into epigenetic regulation of resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms and therapeutic opportunities |
| title_full | Correction: New insights into epigenetic regulation of resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms and therapeutic opportunities |
| title_fullStr | Correction: New insights into epigenetic regulation of resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms and therapeutic opportunities |
| title_full_unstemmed | Correction: New insights into epigenetic regulation of resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms and therapeutic opportunities |
| title_short | Correction: New insights into epigenetic regulation of resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms and therapeutic opportunities |
| title_sort | correction: new insights into epigenetic regulation of resistance to pd-1/pd-l1 blockade cancer immunotherapy: mechanisms and therapeutic opportunities |
| topic | Publisher Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764574/ https://www.ncbi.nlm.nih.gov/pubmed/36536374 http://dx.doi.org/10.1186/s40164-022-00359-x |
| work_keys_str_mv | AT daimengyuan correctionnewinsightsintoepigeneticregulationofresistancetopd1pdl1blockadecancerimmunotherapymechanismsandtherapeuticopportunities AT liumiao correctionnewinsightsintoepigeneticregulationofresistancetopd1pdl1blockadecancerimmunotherapymechanismsandtherapeuticopportunities AT yanghua correctionnewinsightsintoepigeneticregulationofresistancetopd1pdl1blockadecancerimmunotherapymechanismsandtherapeuticopportunities AT kucukcan correctionnewinsightsintoepigeneticregulationofresistancetopd1pdl1blockadecancerimmunotherapymechanismsandtherapeuticopportunities AT youhua correctionnewinsightsintoepigeneticregulationofresistancetopd1pdl1blockadecancerimmunotherapymechanismsandtherapeuticopportunities |